Characteristic | n (%) | |
---|---|---|
Age (years) | Median: 56 | Â |
Range: 30–75 | ||
HR status | HR+ | 65 (81.3%) |
HR− | 15 (18.8%) | |
HER2 status | HER2+ | 12 (15.0%) |
HER2++ | 18 (22.5%) | |
HER2+++ | 1 (1.3%) | |
HER2− | 44 (55.0%) | |
Unknown | 5 (6.3%) | |
AJCC/TNM stage | 2a | 19 (23.8%) |
2b | 26 (32.5%) | |
3a | 23 (28.8%) | |
3b | 4 (8.8%) | |
3c | 7 (8.8%) | |
4 | 1 (1.3%) | |
Pathological diagnosis of infiltrating ductal carcinoma | IDC2 | 71 (88.8%) |
IDC3 | 6 (7.5%) | |
Others | 3 (3.8%) |